Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SLN compared with ALEC: revenue, margins and what each company keeps, and the suppliers and customers both name
SLN
Silence Therapeutics plc
Change
Mkt cap
Revenue
Revenue
ALEC
Alector, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SLN
Silence Therapeutics plc
vs
ALEC
Alector, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SLN: latest quarter is a loss; flow not drawable. ALEC: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SLN
2
AZN
AstraZeneca AB
customer
—
Hansoh Pharmaceutical
unlisted
customer
Shared
0
No shared counterparties.
Only ALEC
3
ABBV
AbbVie
customer
GSK
GlaxoSmithKline
customer
—
Adimab
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
SLN
Silence Therapeutics plc
Change
19.80
▲
+0.19%
· post 19.80
Mkt cap
$933.6M
Revenue
$422,000
Q1 FY26
Revenue
$559,000
FY25
ALEC
Alector, Inc.
Change
2.05
▼
−4.65%
· post 2.09
Closed
Nov 3 '26
Mkt cap
$228.9M
Revenue
$3M
Q2 FY26
Revenue
$21M
FY25
vs
Compare
Closed
Nov 3 '26
SLN
Silence Therapeutics plc
vs
ALEC
Alector, Inc.
19.80
▲
+0.19%
post 19.80
Price
2.05
▼
−4.65%
post 2.09
$933.6M
Mkt cap
$228.9M
Q1 FY26
$422,000
Revenue
$3M
Q2 FY26
FY25
$559,000
Revenue
$21M
FY25
Change
Change
SLN
19.80
▲
+0.19%
vs
ALEC
2.05
▼
−4.65%
Closed
Nov 3 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SLN, solid
ALEC, dashed